Whittingham S, Buckley J D, Mackay I R
Clin Exp Immunol. 1978 Nov;34(2):170-8.
The secondary antibody response to 5.0 microgram flagellin was studied by haemagglutination in 132 healthy or convalescent subjects given a primary challenge with 5.0 microgram flagellin from 1 to 44 months previously. The peak titre, expressed as total antibody, occurred at 2 weeks and was mainly immunoglobulin (Ig)G. The magnitude of the titre of total antibody was influenced predominantly by that of total antibody in the primary response (P less than 0.001), the interval between primary and secondary responses (P less than 0.005) and the subjects' age (P less than 0.05) and sex (P less than 0.08). Together these accounted for 23% of the variability observed in the secondary response, with total antibody titre in the primary response accounting for 11% of the variability. The titre of IgG antibody was likewise influenced by these four variables, but the influence of age or sex on IgG antibody was not statistically significant. In human vaccination programmes, choice of the appropriate interval between primary and booster inoculations could increase prophylactic effectiveness and, if two inoculations were to prove as effective as three, there would be reduced work and increased public acceptance. Moreover, the demonstrable capacity for responsiveness of aged and debilitated persons should encourage the wider use of appropriate prophylactic immunization in these groups.
对132名健康或正在康复的受试者进行了研究,这些受试者在1至44个月前曾接受过5.0微克鞭毛蛋白的初次刺激,此次通过血凝试验研究了他们对5.0微克鞭毛蛋白的二次抗体反应。以总抗体表示的峰值滴度在2周时出现,主要为免疫球蛋白(Ig)G。总抗体滴度的大小主要受初次反应中总抗体滴度(P<0.001)、初次和二次反应之间的间隔(P<0.005)、受试者年龄(P<0.05)和性别(P<0.08)的影响。这些因素共同占二次反应中观察到的变异性的23%,其中初次反应中的总抗体滴度占变异性的11%。IgG抗体滴度同样受这四个变量的影响,但年龄或性别对IgG抗体的影响无统计学意义。在人类疫苗接种计划中,选择初次和加强接种之间的合适间隔可以提高预防效果,如果两次接种证明与三次接种一样有效,那么工作量将减少,公众接受度将提高。此外,老年人和体弱者可证明的反应能力应鼓励在这些人群中更广泛地使用适当的预防性免疫。